| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |